Modelling Charcot-Marie-Tooth disease in a dish reveals common cell type-specific alterations.

Brain

Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, School of Clinical Medicine, University of Cambridge, Cambridge, UK.

Published: September 2021

This scientific commentary refers to ‘Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction’, by Van Lent (doi:10.1093/brain/awab226).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418343PMC
http://dx.doi.org/10.1093/brain/awab278DOI Listing

Publication Analysis

Top Keywords

modelling charcot-marie-tooth
4
charcot-marie-tooth disease
4
disease dish
4
dish reveals
4
reveals common
4
common cell
4
cell type-specific
4
type-specific alterations
4
alterations scientific
4
scientific commentary
4

Similar Publications

Background: Spinal muscular atrophy with respiratory distress type 1 (SMARD1) and Charcot-Marie-Tooth type 2S (CMT2S) typically present before age 10. Genetic factors account for up to 50 % of neuropathies, which often display varied symptoms. Mutations in the IGHMBP2 gene are associated with both CMT2S and SMARD1, resulting in a rare clinical condition marked by axonal neuropathy, spinal muscular atrophy, respiratory distress, and muscle weakness.

View Article and Find Full Text PDF

HSPB1 [heat shock protein family B (small) member 1] and HSPB8 are essential molecular chaperones for neuronal proteostasis, as they prevent protein aggregation. Mutant HSPB1 and HSPB8 primarily harm peripheral neurons, resulting in axonal Charcot-Marie-Tooth neuropathies (CMT2). Macroautophagy/autophagy is a shared mechanism by which HSPB1 and HSPB8 mutations cause neuronal dysfunction.

View Article and Find Full Text PDF

The core component of the class III phosphatidylinositol 3-kinase complex, Beclin 1, takes part in different protein networks, thus switching its role from inducing autophagy to regulating autophagosomal maturation and endosomal trafficking. While assessed in neurons, astrocytes, and microglia, its role is far less investigated in myelinating glia, including Schwann cells (SCs), responsible for peripheral nerve myelination. Remarkably, the dysregulation in endosomal trafficking is emerging as a pathophysiological mechanism underlying peripheral neuropathies, such as demyelinating Charcot-Marie-Tooth (CMT) diseases.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates neuromuscular junction (NMJ) function in patients with Charcot-Marie Tooth (CMT) disease and explores the potential for improving muscle strength through ClC-1 channel inhibition.
  • Results showed significant NMJ abnormalities in CMT patients, such as increased jitter and blocking, which correlated with weaker muscle performance and endurance.
  • Preclinical experiments indicated that a new drug, NMD670, improved muscle strength and endurance in CMT mice, suggesting that targeting NMJ dysfunction might offer a new therapeutic approach for CMT patients.
View Article and Find Full Text PDF

Exploring the phenotypic spectrum and osteopenia mechanisms in Yunis-Varón syndrome.

Genet Med Open

March 2024

Medical Genetics Division, Department of Pediatrics, CHU Sainte-Justine, Montreal, QC, Canada.

Article Synopsis
  • Biallelic variants in specific genes cause Yunis-Varón syndrome (YVS), which involves issues like skeletal deformities, facial abnormalities, and neurological problems.
  • A study of five new YVS cases revealed symptoms aligning with YVS and neurological conditions, such as brain malformations and developmental delays.
  • Research showed that in mice, osteopenia (low bone density) was more linked to reduced bone formation than bone degradation, emphasizing the need for further studies on genetic impacts and symptoms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!